NYSE:TMHC • US87724P1066
ChartMill assigns a Buy % Consensus number of 79% to TMHC. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-12 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-12 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-16 | B of A Securities | Downgrade | Buy -> Neutral |
| 2026-01-07 | Citizens | Initiate | Market Outperform |
| 2025-10-23 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-10 | B of A Securities | Maintains | Buy -> Buy |
| 2025-09-18 | B of A Securities | Maintains | Buy -> Buy |
| 2025-07-23 | Seaport Global | Upgrade | Neutral -> Buy |
| 2025-05-05 | B of A Securities | Initiate | Buy |
| 2025-04-24 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-23 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-04-08 | Barclays | Maintains | Overweight -> Overweight |
| 2025-03-06 | Seaport Global | Upgrade | Sell -> Neutral |
| 2025-02-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-13 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-01-27 | Seaport Global | Downgrade | Neutral -> Sell |
| 2024-12-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-12-11 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2024-10-29 | Raymond James | Reiterate | Outperform -> Outperform |
| 2024-10-25 | Wedbush | Upgrade | Neutral -> Outperform |
| 2024-10-24 | BTIG | Maintains | Buy -> Buy |
| 2024-10-24 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-24 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-23 | Wedbush | Reiterate | Neutral -> Neutral |
| 2024-08-19 | BTIG | Upgrade | Neutral -> Buy |
| 2024-08-12 | Zelman & Assoc | Upgrade | Neutral -> Outperform |
| 2024-07-25 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-07-25 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-07-25 | Wedbush | Maintains | Neutral -> Neutral |
| 2024-07-24 | Raymond James | Initiate | Outperform |
16 analysts have analysed TMHC and the average price target is 77.23 USD. This implies a price increase of 13.73% is expected in the next year compared to the current price of 67.91.
The consensus rating for TAYLOR MORRISON HOME CORP (TMHC) is 78.75 / 100 . This indicates that analysts generally have a positive outlook on the stock.